Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intranasal apomorphine. Nastech Pharmaceutical.

Muammer Kendirci1, Wayne J G Hellstrom

  • 1Section of Andrology and Male Infertility, Department of Urology, Tulane University, Health Sciences Center, 1430 Tulane Avenue SL-4, New Orleans, LA 70112, USA. whellst@tulane.edu

Idrugs : the Investigational Drugs Journal
|May 22, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sexual dysfunctions in male patients with infertility: recommendations from the Fifth International Consultation for Sexual Medicine (ICSM 2024).

Sexual medicine reviews·2026
Same author

History of Peyronie's disease: from early descriptions to modern treatments.

Sexual medicine reviews·2025
Same author

Scoping review to assess the role of the immune system in the pathophysiology of vulvodynia and post-orgasmic illness syndrome.

Sexual medicine reviews·2025
Same author

Role of Metabolic Syndrome in Male Fertility: Is It a Risk Factor?

Archivos espanoles de urologia·2025
Same author

Addressing unmet needs for patients with erectile dysfunction: a narrative review of topical therapies.

Sexual medicine·2025
Same author

Advances in penile prosthetics: current trends and future directions in erectile dysfunction treatment.

International journal of impotence research·2024

Nastech Pharmaceutical is developing a novel nasal apomorphine spray. This formulation aims to treat both erectile dysfunction and female sexual dysfunction.

Area of Science:

  • Pharmacology
  • Drug Delivery Systems
  • Sexual Health

Background:

  • Erectile dysfunction (ED) and female sexual dysfunction (FSD) are common conditions affecting millions globally.
  • Current treatments for ED and FSD have limitations in efficacy, side effect profiles, or administration methods.

Purpose of the Study:

  • To investigate the potential of a novel nasal formulation of apomorphine.
  • To evaluate the efficacy and safety of nasal apomorphine for treating ED and FSD.

Main Methods:

  • Development of a proprietary nasal delivery system for apomorphine.
  • Preclinical studies to assess pharmacokinetic and pharmacodynamic properties.
  • Clinical trials to evaluate safety and efficacy in patients with ED and FSD.

Related Experiment Videos

Main Results:

  • The nasal formulation demonstrated rapid absorption and bioavailability.
  • Preliminary data suggests potential efficacy in improving sexual function in both men and women.
  • The formulation was generally well-tolerated with a manageable side effect profile.

Conclusions:

  • Nasal apomorphine represents a promising new therapeutic option for ED and FSD.
  • The nasal route offers a potentially convenient and effective alternative to existing treatments.
  • Further research and clinical trials are warranted to confirm these findings.